Novack Jeffrey Adam sold $124K of CDNA
Novack Jeffrey Adam (Secretary and General Counsel) sold 2,688 shares of CareDx, Inc. (CDNA) at an average of $46.26 ($46.15–$46.75, $0.12M total) across 2 trades on 2026-08-05 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale size, price range, and post-transaction holdings by the company’s Secretary and General Counsel under a 10b5-1 plan.
Market read
Traders may note insider selling, but 10b5-1 structure typically reduces signal strength versus discretionary sales.
What to watch
The filing does not indicate intent beyond the pre-arranged plan, and the article lacks any accompanying company-specific negative development.
Background
The article is an SEC Form 4 insider transaction disclosure for CareDx, Inc. (CDNA).
Ticker impact
CareDx Form 4 shows insider (Secretary and General Counsel) sold 2,688 shares in open-market trades under a 10b5-1 plan on Aug 5.
Limited near-term impact; any reaction is likely muted unless paired with other negative company-specific news.
The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan, and the article provides no new fundamentals beyond the sale details.
Market effects
No clear sector read-through from a single routine 10b5-1 sale.
None.
None.
Counterpoint
10b5-1 sales can be misread as bearish; the plan timing may be unrelated to near-term performance expectations.
Key entities
- issuerCareDx, Inc.
Subject of the Form 4 insider transaction disclosure (CDNA).
- insiderNovack Jeffrey Adam
Secretary and General Counsel who sold 2,688 shares under a 10b5-1 plan.
